So proud that our rockstar founders Miriam Rivera and Clint Korver were recognized by Blueprint Capital Advisors LLC in their DEIC Power 100 as outstanding asset managers. Our thesis has always been... diversity is profitable and our mission is inclusive capital in the industry. We are honored to be included with such an illustrious group of icons and asset managers, some of whom we count as LPs, friends, co-investors and even Ulupreneurs. https://lnkd.in/gzeSYDU4
Ulu Ventures
Venture Capital and Private Equity Principals
Palo Alto, California 4,950 followers
A top seed stage venture fund focused on innovation across enterprise, fintech, consumer, health and sustainability.
About us
Ulu Ventures is a top seed stage venture fund in Silicon Valley focused on innovation across enterprise, fintech, consumer, health, and sustainability. Ulu generates great financial results using a disciplined, repeatable decision-making process that analyzes risk-reward trade-offs and also reduces cognitive bias. The majority of Ulu portfolio companies are founded by diverse teams that include women, minority, URM and/or immigrant founders. Ulu’s investment thesis is based on the concept that diversity is profitable. The firm has more than $200M AUM, 10 unicorns in the portfolio and is dedicated to increasing diversity in the entrepreneurial and assets under management communities.
- Website
-
http://www.uluventures.com
External link for Ulu Ventures
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 11-50 employees
- Headquarters
- Palo Alto, California
- Type
- Privately Held
- Founded
- 2008
Locations
-
Primary
Get directions
115 Everett Ave
Palo Alto, California 94301, US
Employees at Ulu Ventures
-
Trina Weller
VP Analytics, Ulu Ventures and Executive Educator, Strategic Decisions Group
-
Steve Reale
Partner & CFO at Ulu Ventures
-
David P. White
Executive Coach, Strategic Advisor, Public Speaker and Board Member of several companies and organizations. Building a legacy to drive positive…
-
Loren Ford
JD, APCC, AMFT Psychotherapy & Counseling
Updates
-
So great to see entrepreneurial creativity and hard work successfully attracting the FDA's attention on the potential of AI to enhance clinical trials in anxiety and depression. Proud to be an investor in Marc Aafjes and Deliberate!
Our FDA Milestone! FDA announces that Deliberate’s AI-COA™ is Part of ISTAND Program, Breaking New Ground in AI and Mental Health! 📄 Read our press release: https://bit.ly/3S6cZjC 📄 Read FDA press release: https://bit.ly/3Hz2Nvj I’m thrilled to announce a groundbreaking milestone for Deliberate AI: Our first AI-COA™ model, for Depression and Anxiety measurement, has been officially included in the FDA’s Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program. This is not just a win for us; it's a pioneering moment in AI/ML, Digital Health Technology (DHT), and the fields of Psychiatry and Neuroscience. 💊 Advancing Pharma: Our cutting-edge MultiModal AI platform is set to transform psychiatric drug development and evaluation. By quantitatively capturing mental health symptoms, our AI-COA™ models offer a consistent, bias-free assessment, enhancing the precision and reliability of clinical trials. This means significantly more powerful, efficient, and faster drug development processes, leading to improved patient care and significant public health advancements. 🌟 A Personal Milestone: As Founder & CEO, this milestone is very personal to me. It represents years of our team's dedication and the relentless pursuit of our mission to empower mental health care through precision, empathy, and innovation. 🙏 Heartfelt Thanks: A huge shoutout to our talented team at Deliberate AI, past and present -- your hard work and dedication have made this possible. Also, a special thanks to leading experts in the field, Maurizio Fava and René S. Kahn MD, PhD, for your statements emphasizing the significance of this milestone. 💼 To Our Investors and Future Partners: This achievement exemplifies our potential for growth and scalability in the clinical trials and healthcare sectors. Deliberate AI is not just innovating; we're leading the way in AI for mental health. We're enabling 3 transformative and reinforcing shifts: Advanced Diagnostics and Monitoring, Ambient Clinical Intelligence and Precision Therapy Enablement. Let’s connect to explore how we can drive the future of mental health together. 👀 Stay Tuned: The inclusion of AI in drug development and healthcare is just starting, as is our journey. Follow us here on LinkedIn and sign up for our newsletter to not miss out on more exciting updates coming soon! 📩 Newsletter Sign-Up: https://bit.ly/3SI0NYd 🤝 Join the Conversation: What do you think the future holds for AI in healthcare? What are some of your questions and considerations of the use of AI in late-stage Clinical Trials? Share your thoughts below! #DigitalHealth #HealthTech #Medtech #Multimodal #AI #PharmaInnovation #ClinicalTrials #Depression #Anxiety #AIEthics ##AIinHealthcare Mary Fortson, Nurah K., Kapildev Neupane, Rachna Saralkar, MD, MS, Katie Aafjes-van Doorn, Jeff Cohn, Marcelo Cicconet, Ben Barone, Jeremy Jones.
-
Ulu Ventures partner Steve Reale alerts founders to pitfalls of SAFEs and common sense ways to play the cap table game to win. #startups #startupstrategies #captable #kauffmanfellows
-
Kudos to Ulupreneurs Kat Garcia and Shahriar Kabir co-founders of Ground featured in Forbes for highlighting how being entrepreneurs is similar to playing high level sports...it takes hard work, grit and talent! Great analogy!
The Entrepreneurial Grind With Co-Founders Of Ground
forbes.com
-
We are proud and excited to welcome our newest investment team member and Latina leader, Senior Associate Andrea Bogarin! What a wonderful way to wrap up the celebration of #HispanicHeritageMonth! An immigrant, Andrea is passionate about working with diverse founders solving problems for underserved communities. Congratulations to our new Champion of bridge building! #latinaleader
Andrea Bogarin
https://uluventures.com
-
Venture investment till remains stuck at 2% for all Latinx funding. At Ulu Ventures, we believe Latinx entrepreneurs are positioned to lead the next wave of tech innovation for the emerging majority of workers and consumers.
-
Great profile in Inc. Magazine featuring Ulupreneur Elise Smith CEO of Praxis Labs and why she wants everyone (especially the press) to focus more on showcasing the impact of minority founders and emphasizing the mission behind their businesses instead of the dollars raised. We're proud to be investors in Praxis!
Elise Smith Is Among the Most-Funded Black Women in Tech. She Doesn't Want to Talk About Funding
inc.com
-
Increasing diversity throughout the entrepreneurial and investment communities has always been a mission at Ulu Ventures, especially for our CEO and co-founder Miriam Rivera. Investing in diverse entrepreneurs is critical, but it's also critical for founders to help reduce bias by creating diverse startup boards. Hear Miriam's thoughts on ways to do just that. #diversityandinclusion #diverseleadership #diversefounders
Promoting Diversity on Startup Boards
https://uluventures.com
-
Big shoutout to Ulupreneur ✳️Roberto Peñacastro Ortega and the Leadsales team on their selection to the latest cohort of the Google for Startups Black and Latino Founders Fund! Congrats to all selected. #latinoleaders
-